Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
31.43
+2.43 (8.38%)
At close: Mar 4, 2026, 4:00 PM EST
30.06
-1.37 (-4.36%)
Pre-market: Mar 5, 2026, 4:54 AM EST
Sensei Biotherapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Sensei Biotherapeutics stock have an average target of 72.5, with a low estimate of 30 and a high estimate of 100. The average target predicts an increase of 130.67% from the current stock price of 31.43.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 5, 2025.
Analyst Ratings
The average analyst rating for Sensei Biotherapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $30 | Strong Buy | Maintains | $5 → $30 | -4.55% | Aug 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +218.17% | Jun 2, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $70 → $80 | Buy | Maintains | $70 → $80 | +154.53% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +154.53% | Mar 28, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-18.53
from -24.01
EPS Next Year
-15.35
from -18.53
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -19.08 | -15.80 | |
| Avg | -18.53 | -15.35 | |
| Low | -17.81 | -14.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.